Serbian tennis player Novak Djokovic owns a majority stake in a biotechnology firm, which is working on a way to immunise people against Covid without a vaccine. The Serbian tennis star has been vocal in his opposition to jabs, and appears to be actively invested in finding a way for others like himself to be protected without the need for a needle.

It was revealed by Reuters on Wednesday that Djokovic has purchased an 80% share of QuantBioRes, which is headquartered in Copenhagen.

The firm is working on a way to counter the virus without the need for people to get the vaccine against coranavirus.


The company’s chief executive Ivan Loncarevic told Reuters that Djokovic made the investment more than a year ago, clarifying that it was not a response to his recent saga in Australia.

He subsequently told the Financial Times that he had not spoken to Djokovic, who has won more than $150m in prize money, since November and that the tennis star was “not anti-vax”.

Djokovic travelled to Australia at the start of the month with the plan of taking part in the Australian Open, but was held at the airport in Melbourne over a visa issue.

Eventually, the day before the tournament began, the Federal Court upheld the Australian government’s decision and deported the world number one tennis player.

Djokovic, who may also be barred from defending his French Open title in Roland Garros in May after the French government ruled on Monday that all athletes will have to be vaccinated in order to attend and compete in sporting events, acquired his stake in the company in June 2020.